ReviewMemorias do Instituto Oswaldo Cruz2025
Beyond the first case of Chagas disease: the Berenice strain as a model for understanding long-term Trypanosoma cruzi infection.
Review in Memorias do Instituto Oswaldo Cruz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here, we review the key findings on the genetic characterisation of Berenice strains of Trypanosoma cruzi isolated from a 2-year-old child, Berenice, the first patient with Chagas disease described in the literature in 1909. Be-62 and Be-78 strains were isolated from Berenice when she was 55 and 71 years old, respectively. They were comparatively studied, revealing several important genetic differences that indicated the presence of heterogeneous T. cruzi populations within the infection of patient Berenice. Recently, a high-quality whole-genome assembly was generated using the strain Be-62, which was isolated in 1962. Even after decades-long persistence in the patient, there is a high level of conservation in synteny between Be-62 and different T. cruzi lineages. It has been suggested that T. cruzi diversity is driven by the evolution of multigene families encoding target antigens of anti-parasite immune responses, located in disruptive regions of the genome. Most studies of Berenice have been conducted on genomic bulk samples, resulting in a biased analysis that favours the dominant genotype. Single-cell omics technologies enable us to study the genetic diversity within an infection caused by protozoan parasites in detail. Sequencing individual genomes of Berenice strains will be the key to elucidating the population structure of individual infections, the dynamics of parasite populations, and adaptive mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.